161 related articles for article (PubMed ID: 35629265)
1. CD44 Mediates Oral Squamous Cell Carcinoma-Promoting Activity of MRE11 via AKT Signaling.
Yuan SF; Hung AC; Hsu CW; Lan TH; Su CW; Chi TC; Chang YC; Chen YK; Wang YY
J Pers Med; 2022 May; 12(5):. PubMed ID: 35629265
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-485-5p targets keratin 17 to regulate oral cancer stemness and chemoresistance via the integrin/FAK/Src/ERK/β-catenin pathway.
Jang TH; Huang WC; Tung SL; Lin SC; Chen PM; Cho CY; Yang YY; Yen TC; Lo GH; Chuang SE; Wang LH
J Biomed Sci; 2022 Jun; 29(1):42. PubMed ID: 35706019
[TBL] [Abstract][Full Text] [Related]
3. Cancer Stem Cell Markers, CD44 and ALDH1, for Assessment of Cancer Risk in OPMDs and Lymph Node Metastasis in Oral Squamous Cell Carcinoma.
Dhumal SN; Choudhari SK; Patankar S; Ghule SS; Jadhav YB; Masne S
Head Neck Pathol; 2022 Jun; 16(2):453-465. PubMed ID: 34655409
[TBL] [Abstract][Full Text] [Related]
4. CD44 related stemness maneuvers oral squamous cell carcinoma biology.
Tandon A; Singh NN; Gulati N
Indian J Pathol Microbiol; 2022; 65(2):268-273. PubMed ID: 35435358
[TBL] [Abstract][Full Text] [Related]
5. Crosstalk between Raf-MEK-ERK and PI3K-Akt-GSK3β signaling networks promotes chemoresistance, invasion/migration and stemness via expression of CD44 variants (v4 and v6) in oral cancer.
Kashyap T; Pramanik KK; Nath N; Mishra P; Singh AK; Nagini S; Rana A; Mishra R
Oral Oncol; 2018 Nov; 86():234-243. PubMed ID: 30409306
[TBL] [Abstract][Full Text] [Related]
6. IL-1RA promotes oral squamous cell carcinoma malignancy through mitochondrial metabolism-mediated EGFR/JNK/SOX2 pathway.
Yuan SF; Wang YM; Chan LP; Hung AC; Nguyen HDH; Chen YK; Hu SC; Lo S; Wang YY
J Transl Med; 2023 Jul; 21(1):473. PubMed ID: 37461111
[TBL] [Abstract][Full Text] [Related]
7. Combined overexpression of cadherin 6, cadherin 11 and cluster of differentiation 44 is associated with lymph node metastasis and poor prognosis in oral squamous cell carcinoma.
Ma C; Zhao JZ; Lin RT; Zhou L; Chen YN; Yu LJ; Shi TY; Wang M; Liu MM; Liu YR; Zhang T
Oncol Lett; 2018 Jun; 15(6):9498-9506. PubMed ID: 29805672
[TBL] [Abstract][Full Text] [Related]
8. Lactic acid-induced M2-like macrophages facilitate tumor cell migration and invasion via the GPNMB/CD44 axis in oral squamous cell carcinoma.
Lin Y; Qi Y; Jiang M; Huang W; Li B
Int Immunopharmacol; 2023 Nov; 124(Pt B):110972. PubMed ID: 37806107
[TBL] [Abstract][Full Text] [Related]
9. MSX2 represses tumor stem cell phenotypes within oral squamous cell carcinomas via SOX2 degradation.
Keyimu R; Tuerdi M; Zhao Z
Exp Biol Med (Maywood); 2021 Dec; 246(24):2660-2670. PubMed ID: 34435915
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of c-fos promotes cell invasion and migration via CD44 pathway in oral squamous cell carcinoma.
Dong C; Ye DX; Zhang WB; Pan HY; Zhang ZY; Zhang L
J Oral Pathol Med; 2015 May; 44(5):353-60. PubMed ID: 25482572
[TBL] [Abstract][Full Text] [Related]
11. Prognostic evaluation of tumour budding in oral squamous cell carcinoma: Evidenced by CD44 expression as a cancer stem cell marker.
Niranjan KC; Raj M; Hallikeri K
Pathol Res Pract; 2023 Nov; 251():154883. PubMed ID: 37898041
[TBL] [Abstract][Full Text] [Related]
12. FERMT1 knockdown inhibits oral squamous cell carcinoma cell epithelial-mesenchymal transition by inactivating the PI3K/AKT signaling pathway.
Wang X; Chen Q
BMC Oral Health; 2021 Nov; 21(1):598. PubMed ID: 34814915
[TBL] [Abstract][Full Text] [Related]
13. Role of Stromal Fibroblast-Induced WNT7A Associated with Cancer Cell Migration Through the AKT/CLDN1 Signaling Axis in Oral Squamous Cell Carcinoma.
Kayamori K; Katsube KI; Hirai H; Harada H; Ikeda T
Lab Invest; 2023 Oct; 103(10):100228. PubMed ID: 37541622
[TBL] [Abstract][Full Text] [Related]
14. Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness, EMT traits, and lymph node metastasis.
Yu CC; Chen PN; Peng CY; Yu CH; Chou MY
Oncotarget; 2016 Apr; 7(15):20180-92. PubMed ID: 26933999
[TBL] [Abstract][Full Text] [Related]
15. MRE11 promotes oral cancer progression through RUNX2/CXCR4/AKT/FOXA2 signaling in a nuclease-independent manner.
Wang YY; Chen YK; Lo S; Chi TC; Chen YH; Hu SC; Chen YW; Jiang SS; Tsai FY; Liu W; Li RN; Hsieh YC; Huang CJ; Yuan SF
Oncogene; 2021 May; 40(20):3510-3532. PubMed ID: 33927349
[TBL] [Abstract][Full Text] [Related]
16. POLE2 Regulates Apoptosis of Oral Squamous Cell Carcinoma Cells through the PI3K/AKT Signaling Pathway.
Sun MY; Wang L; Shen ZY
Curr Med Sci; 2023 Dec; 43(6):1162-1172. PubMed ID: 38079056
[TBL] [Abstract][Full Text] [Related]
17. CCL21/CCR7 interaction promotes EMT and enhances the stemness of OSCC via a JAK2/STAT3 signaling pathway.
Chen Y; Shao Z; Jiang E; Zhou X; Wang L; Wang H; Luo X; Chen Q; Liu K; Shang Z
J Cell Physiol; 2020 Sep; 235(9):5995-6009. PubMed ID: 32017846
[TBL] [Abstract][Full Text] [Related]
18. Ephrin-B2 reverse signaling regulates progression and lymph node metastasis of oral squamous cell carcinoma.
Sasabe E; Tomomura A; Tomita R; Sento S; Kitamura N; Yamamoto T
PLoS One; 2017; 12(11):e0188965. PubMed ID: 29190834
[TBL] [Abstract][Full Text] [Related]
19. MiR-455-5p suppresses PDZK1IP1 to promote the motility of oral squamous cell carcinoma and accelerate clinical cancer invasion by regulating partial epithelial-to-mesenchymal transition.
Hsiao SY; Weng SM; Hsiao JR; Wu YY; Wu JE; Tung CH; Shen WL; Sun SF; Huang WT; Lin CY; Chen SH; Hong TM; Chen YL; Chang JY
J Exp Clin Cancer Res; 2023 Feb; 42(1):40. PubMed ID: 36737832
[TBL] [Abstract][Full Text] [Related]
20. BST2 regulated by the transcription factor STAT1 can promote metastasis, invasion and proliferation of oral squamous cell carcinoma via the AKT/ERK1/2 signaling pathway.
Shan F; Shen S; Wang X; Chen G
Int J Oncol; 2023 Apr; 62(4):. PubMed ID: 36929425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]